High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association.

J N Atkins; H B Muss; D Case; J Brockschmidt; F M Schnell; M O'Rourke; T H Grote; J H West; S Anthony; V Stanley

doi:10.1097/00000421-199112000-00012

High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association.

Identifier:nobleid.org/w1/20260515/3FE03322

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3FE03322.svg?ark=w1%2F20260515%2F3FE03322)](https://nobleid.org/work/w1/20260515/3FE03322)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association.

Identifier:nobleid.org/w1/20260515/3FE03322

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3FE03322.svg?ark=w1%2F20260515%2F3FE03322)](https://nobleid.org/work/w1/20260515/3FE03322)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work